Tissue engineering: The big picture on growing small intestines

June 07, 2019

Babies born prematurely often face intense medical challenges, including intestines that are underdeveloped or diseased. While an intestine transplant can benefit some patients, many babies are simply too small to endure this procedure. Children's Hospital Los Angeles surgeon Tracy Grikscheit, MD, is a leader in the field of tissue engineering - growing intestines from stem cells. In an article published in the journal Cell Stem Cell, Dr. Grikscheit and co-authors highlight how stem cell therapy is poised to become a game-changer for these babies.

Some premature babies are born with severely underdeveloped gastrointestinal tracts or can develop diseases like necrotizing enterocolitis, which attacks the intestines. In severe cases, surgical removal of the affected bowels (intestines) must be performed. This can have dire consequences.

Most nutrient and water absorption occurs in the small intestine, so if patients are not left with enough healthy tissue, they can suffer from serious complications like malnutrition or dehydration - also known as short bowel syndrome. In order to get the proper nutrients, patients may have to be fed through a feeding tube or intravenously- through a needle into the bloodstream. In the most severe cases of short bowel syndrome, small intestine transplant from donor tissue is the only answer; but this, too, comes with its own list of problems. Babies must be big enough for this procedure, which often means they need to wait several months. Even then, the road is not an easy one. Patients must take anti-rejection medications, which have their own side effects and the success rate of transplantation is only about fifty percent.

With such challenges, the future seems bleak for these babies. To Dr. Grikscheit, this is not acceptable. She wants more for her patients and she envisions a world in which missing portions of intestines can be grown.

Scientists like Dr. Grikscheit investigate growth of new tissue from stem cells to treat babies with severe intestinal impairments. "Stem cell therapies would really improve upon current options," she says. "Right now, these babies can either get a transplant, or live on IV nutrition, which really impacts the way they can interact with the world and develop. There has to be a better way."

The Cell Stem Cell article was written by Dr. Grikscheit and colleagues as part of INTENS, a European consortium that fosters research to treat children with intestinal failure through tissue engineering. Tissue engineering is the process of producing new tissue in the laboratory from stem cells. The publication describes the progress researchers have made as well as the challenges scientists face in bringing stem cell therapy to patients.

Stem cells have the capability of developing into any cell type, making them ideal starting material for organ repair. The paper discusses two main ways in which stem cells could potentially treat babies with these intestinal issues. Stem cells can either be taken from the patient's own intestine or "off the shelf" - from a stock source of stem cells that can be engineered into intestinal tissue. The two pathways each offer distinct advantages to patients and the treatment type could depend on the condition each child faces.

Research in this field is showing promise for future therapy. Recent progress has allowed researchers to generate larger amounts of intestinal tissue than ever before.

"We're not yet at the stage of delivering this therapy to babies but we're developing the road map," says Dr. Grikscheit. "We're getting closer."
Co-senior authors of the article include Dr. Kim B. Jensen of the University of Copenhagen and Dr. Paolo De Coppi of Great Ormond Street Hospital and University College London. The INTENS consortium is supported by the Horizon 2020 Research and Innovation Programme (668294).

About Children's Hospital Los Angeles

Children's Hospital Los Angeles has been ranked the top children's hospital in California and sixth in the nation for clinical excellence by the prestigious U.S. News & World Report Honor Roll. The Saban Research Institute at CHLA is one of the largest and most productive pediatric research facilities in the United States. CHLA also is one of America's premier teaching hospitals through its affiliation since 1932 with the Keck School of Medicine of the University of Southern California. For more, visit CHLA.org, the child health blog and the
" target="_blank">research blog

Children's Hospital Los Angeles

Related Stem Cells Articles from Brightsurf:

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.

First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.

Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.

Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.

NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.

Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.

Read More: Stem Cells News and Stem Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.